Figure 2
Figure 2. Cumulative incidence of acute GVHD according to donor statin treatment and type of calcineurin inhibitor (CSP or TAC) for postgrafting immunosuppression. (R) and (D) indicate patient and donor, respectively. (+) and (−) indicate absence or presence, respectively, of statin treatment. P values are derived from log-rank test.

Cumulative incidence of acute GVHD according to donor statin treatment and type of calcineurin inhibitor (CSP or TAC) for postgrafting immunosuppression. (R) and (D) indicate patient and donor, respectively. (+) and (−) indicate absence or presence, respectively, of statin treatment. P values are derived from log-rank test.

Close Modal

or Create an Account

Close Modal
Close Modal